Skip to main content Back to Top
Advertisement

5/26/2023

Hydrocodone and Acetaminophen Tablets

Products Affected - Description

    • Hydrocodone bitartrate and Acetaminophen oral tablet, Amneal, 10 mg / 325 mg, bottle, 500 count, NDC 53746-0110-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Amneal, 10 mg / 325 mg, bottle, 1,000 count, NDC 53746-0110-05
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Amneal, 5 mg / 325 mg, bottle, 100 count, NDC 53746-0109-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Amneal, 5 mg / 325 mg, bottle, 500 count, NDC 53746-0109-05
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Amneal, 7.5 mg / 325 mg, bottle, 500 count, NDC 53746-0115-50
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Amneal, 7.5 mg / 325 mg, bottle, 1,000 count, NDC 53746-0115-11
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Camber, 10 mg / 325 mg, bottle, 100 count, NDC 31722-0997-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Camber, 10 mg / 325 mg, bottle, 500 count, NDC 31722-0997-05
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Camber, 5 mg / 325 mg, bottle, 100 count, NDC 31722-0996-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Camber, 5 mg / 325 mg, bottle, 500 count, NDC 31722-0996-05
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Camber, 7.5 mg / 325 mg, bottle, 100 count, NDC 31722-0942-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Camber, 7.5 mg / 325 mg, bottle, 500 count, NDC 31722-0942-05
    • Hydrocodone bitartrate and Acetaminophen oral tablet, KVK-Tech, 10 mg / 325 mg, bottle, 100 count, NDC 10702-0191-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, KVK-Tech, 10 mg / 325 mg, bottle, 500 count, NDC 10702-0191-50
    • Hydrocodone bitartrate and Acetaminophen oral tablet, KVK-Tech, 10 mg / 325 mg, bottle, 1,000 count, NDC 10702-0191-10
    • Hydrocodone bitartrate and Acetaminophen oral tablet, KVK-Tech, 5 mg / 300 mg, bottle, 500 count, NDC 10702-0192-50
    • Hydrocodone bitartrate and Acetaminophen oral tablet, KVK-Tech, 5 mg / 325 mg, bottle, 100 count, NDC 10702-0189-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, KVK-Tech, 5 mg / 325 mg, bottle, 500 count, NDC 10702-0189-50
    • Hydrocodone bitartrate and Acetaminophen oral tablet, KVK-Tech, 5 mg / 325 mg, bottle, 1,000 count, NDC 10702-0189-10
    • Hydrocodone bitartrate and Acetaminophen oral tablet, KVK-Tech, 7.5 mg / 300 mg, bottle, 100 count, NDC 10702-0193-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, KVK-Tech, 7.5 mg / 325 mg, bottle, 100 count, NDC 10702-0190-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, KVK-Tech, 7.5 mg / 325 mg, bottle, 500 count, NDC 10702-0190-50
    • Hydrocodone bitartrate and Acetaminophen oral tablet, KVK-Tech, 7.5 mg / 325 mg, bottle, 1,000 count, NDC 10702-0190-10
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Major, 10 mg / 325 mg, unit-dose blister pack, 100 count, NDC 00904-6825-61
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Major, 5 mg / 325 mg, unit-dose blister pack, 100 count, NDC 00904-6824-61
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Major, 7.5 mg / 325 mg, unit-dose blister pack, 100 count, NDC 00904-6826-61
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Rhodes, 10 mg / 300 mg, bottle, 100 count, NDC 42858-0238-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Rhodes, 10 mg / 325 mg, bottle, 100 count, NDC 42858-0203-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Rhodes, 10 mg / 325 mg, bottle, 500 count, NDC 42858-0203-50
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Rhodes, 5 mg / 300 mg, bottle, 100 count, NDC 42858-0040-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Rhodes, 5 mg / 325 mg, bottle, 100 count, NDC 42858-0201-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Rhodes, 5 mg / 325 mg, bottle, 500 count, NDC 42858-0201-50
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Rhodes, 7.5 mg / 300 mg, bottle, 100 count, NDC 42858-0139-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Rhodes, 7.5 mg / 325 mg, bottle, 100 count, NDC 42858-0202-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Rhodes, 7.5 mg / 325 mg, bottle, 500 count, NDC 42858-0202-50

Reason for the Shortage

    • Amneal did not provide a reason for the shortage.
    • Camber did not provide a reason for the shortage.
    • Eywa has hydrocodone and acetaminophen tablets available to contracted customers.
    • KVK-Tech did not provide a reason for the shortage.
    • Major did not provide a reason for the shortage.
    • Mallinckrodt refuses to provide availability information.
    • Rhodes did not provide a reason for the shortage.

Available Products

    • Hydrocodone bitartrate and Acetaminophen oral tablet, Eywa, 10 mg / 300 mg, bottle, 100 count, NDC 71930-0044-12
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Eywa, 10 mg / 300 mg, bottle, 500 count, NDC 71930-0044-52
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Eywa, 10 mg / 325 mg, bottle, 100 count, NDC 71930-0021-12
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Eywa, 10 mg / 325 mg, bottle, 500 count, NDC 71930-0021-52
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Eywa, 10 mg / 325 mg, bottle, 1,000 count, NDC 71930-0021-13
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Eywa, 5 mg / 300 mg, bottle, 100 count, NDC 71930-0042-12
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Eywa, 5 mg / 300 mg, bottle, 500 count, NDC 71930-0042-52
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Eywa, 5 mg / 325 mg, bottle, 100 count, NDC 71930-0019-12
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Eywa, 5 mg / 325 mg, bottle, 500 count, NDC 71930-0019-52
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Eywa, 5 mg / 325 mg, bottle, 1,000 count, NDC 71930-0019-13
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Eywa, 7.5 mg / 300 mg, bottle, 100 count, NDC 71930-0043-12
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Eywa, 7.5 mg / 300 mg, bottle, 500 count, NDC 71930-0043-52
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Eywa, 7.5 mg / 325 mg, bottle, 100 count, NDC 71930-0020-12
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Eywa, 7.5 mg / 325 mg, bottle, 500 count, NDC 71930-0020-52
    • Hydrocodone bitartrate and Acetaminophen oral tablet, Eywa, 7.5 mg / 325 mg, bottle, 1,000 count, NDC 71930-0020-13
    • Hydrocodone bitartrate and Acetaminophen oral tablet, KVK-Tech, 10 mg / 300 mg, bottle, 100 count, NDC 10702-0194-01
    • Hydrocodone bitartrate and Acetaminophen oral tablet, KVK-Tech, 5 mg / 300 mg, bottle, 100 count, NDC 10702-0192-01

Estimated Resupply Dates

    • Amneal has all presentations on back order and the company cannot estimate a release date.
    • Camber has all presentations on back order and the company cannot estimate a release date.
    • KVK-Tech has hydrocodone 7.5 mg / 300 mg tablets on allocation. Most other presentations are on back order and the company cannot estimate a release date.
    • Major has hydrocodone 5 mg / 325 mg tablets in 100 count unit-dose packages on back order and the company estimates a release date in late-June 2023. The 7.5 mg / 325 mg tablets in 100 count unit-dose packages are also on back order and the company estimates a release date in mid-June 2023.
    • Rhodes has all presentations on back order and the company cannot estimate a release date.

Updated

Created May 26, 2023 by Leslie Jensen, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

ADVERTISEMENT

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.